Is Estrogen a Therapeutic Target for Glaucoma?

REFERENCES

• Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014;121(11):2081–2090
   PubMed Web of Science ®Google Scholar
• Schmidt KG, Bergert H, Funk RH. Neurodegenerative diseases of the retina and potential for protection and recovery. Curr Neuropharmacol 2008;6:164–178
   PubMed Web of Science ®Google Scholar
• Yucel YH, Zhang Q, Weinreb RN, et al. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res 2003;22:465–481
   PubMed Web of Science ®Google Scholar
• Mukesh BN, McCarty CA, Rait JL, Taylor HR. Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 2002;109(6):1047–1051
   PubMed Web of Science ®Google Scholar
• Vajaranant TS, Pasquale LR. Estrogen deficiency accelerates aging of the optic nerve. Menopause 2012;19(8):942–947
   PubMed Web of Science ®Google Scholar
• Akar Y, Yucel I, Akar ME, et al. Menstrual cycle-dependent changes in visual field analysis of healthy women. Ophthalmologica 2005;219(1):30–35
   PubMed Web of Science ®Google Scholar
• Yucel I, Akar ME, Dora B, et al. Effect of the menstrual cycle on standard achromatic and blue-on-yellow visual field analysis of women with migraine. Can J Ophthalmol 2005;40(1):51–57
   PubMed Web of Science ®Google Scholar
• Akar ME1, Taskin O, Yucel I, Akar Y. The effect of the menstrual cycle on optic nerve head analysis in healthy women. Acta Ophthalmol Scand 2004;82(6):741–745
   PubMedGoogle Scholar
• Guyton AC. Textbook of Medical Physiology Philadelphia, PA: W. B. Saunders Company, 1991
   Google Scholar
• Luu-The V, Labrie F. The intracrine sex steroid biosynthesis pathways. Prog Brain Res 2010;181:177–192
   PubMed Web of Science ®Google Scholar
• Labrie F. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause. J Steroid Biochem Mol Biol 2015;145:133–138
   PubMed Web of Science ®Google Scholar
• Starka L, Obenberger J. In vitro estrone-estradiol-17A interconversion in the cornea, lens, iris and retina of the rabbit eye. Albrecht v Graefes Archiv Klin Exp Ophthal 1975;196:199–204
   PubMedGoogle Scholar
• Starka L, Obenberger J. Steroids and intraocular pressure. J Steroid Biochem 1976;7:979–983
   PubMedGoogle Scholar
• Coca-Prados M, Ghosh S, Wang Y, et al. Sex steroid hormone metabolism takes place in human ocular cells. J Steroid Biochem Mol Biol 2003;86(2):207–216
   PubMed Web of Science ®Google Scholar
• Kumar V, Green S, Stack G, et al. Functional domains of the human estrogen receptor. Cell 1987;51:941–951
   PubMed Web of Science ®Google Scholar
• Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997;277:1508–1510
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863–870
   PubMed Web of Science ®Google Scholar
• Sullivan DA. Tearful relationships? Sex, hormones and aqueous-deficient dry eye. Ocular Surface 2004;2:92–123
   PubMedGoogle Scholar
• Wickham LA, Gao J, Toda I, et al. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol. Scand 2000;78:146–153
   PubMedGoogle Scholar
• Kobayashi K, Kobayashi H, Ueda M, Honda Y. Estrogen receptor expression in bovine and rat retinas. Invest Ophthalmol Vis Sci 1998;39:2105–2510
   PubMed Web of Science ®Google Scholar
• Munaut C, Lambert V, Noel A, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol 2001;85(7):877–882
   PubMed Web of Science ®Google Scholar
• Hewitt SC, Deroo BJ, Korach KS. Signal transduction. A new mediator for an old hormone? Science 2005;307:1625–1630
   PubMed Web of Science ®Google Scholar
• Micevych P, Kuo J, Christensen A. Physiology of membrane oestrogen receptor signalling in reproduction. J Neuroendocrinol 2009;21:249–256
   PubMed Web of Science ®Google Scholar
• Hammes SR, Levin ER. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 2011;152:4489–4495
   PubMed Web of Science ®Google Scholar
• Soltysik K, Czekaj P. Membrane estrogen receptors—Is it an alternative way of estrogen action? J Physiol Pharmacol 2013;64:129–142
   PubMed Web of Science ®Google Scholar
• Renoir J-M, Marsuad V, Lazennec G. Estogen receptor signaling as a target for novel breast cancer therapeutics. Biochem Pharmacol 2013;85:449–465
   PubMed Web of Science ®Google Scholar
• Quereshi IA, Xi XR, Wu XD, et al. Variations in ocular pressure during the menstrual cycle. J Pak Med Assoc 1998;48:37–40
   PubMedGoogle Scholar
• Green K, Cullen PM, Phillips CI. Aqueous humour turnover and intraocular pressure during menstruation. Br J Ophthalmol 1984;68:736–740
   PubMed Web of Science ®Google Scholar
• Vaid RL, Buchh H, Ahuja L. Intraocular pressure during normal menstrual cycle. East Arch Ophthalmol 1975;3:59–62
   Google Scholar
• Lee AJ, Mitchell P, Rochtchina E, Healey PR. Blue Mountains Eye Study. Female reproductive factors and open angle glaucoma: The Blue Mountains Eye Study. Br J Ophthalmol 2003;87(11):1324–1328
   PubMed Web of Science ®Google Scholar
• Pasquale LR, Kang JH. Female reproductive factors and primary open-angle glaucoma in the Nurses' Health Study. Eye (Lond) 2011;25(5):633–641
   PubMed Web of Science ®Google Scholar
• Hulsman CA, Westendorp IC, Ramrattan RS, et al. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 2001;154(2):138–144
   PubMed Web of Science ®Google Scholar
• Pasquale LR, Rosner BA, Hankinson SE, Kang JH. Attributes of female reproductive aging and their relation to primary open-angle glaucoma: a prospective study. J Glaucoma 2007;16(7):598–605
   PubMed Web of Science ®Google Scholar
• Nirmalan PK, Katz J, Robin AL, et al. Female reproductive factors and eye disease in a rural South Indian population: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 2004;45(12):4273–4276
   PubMed Web of Science ®Google Scholar
• Vajaranant TS, Grossardt BR, Maki PM, et al. Risk of glaucoma after early bilateral oophorectomy. Menopause 2014;21(4):391–398
   PubMed Web of Science ®Google Scholar
• Phillips CI, Gore SM. Ocular hypotensive effect of late pregnancy with and without high blood pressure. Br J Ophthalmol 1985;69(2):117–119
   PubMed Web of Science ®Google Scholar
• Qureshi IA, Xi XR, Wu XD. Intraocular pressure trends in pregnancy and in the third trimester hypertensive patients. Acta Obstet Gynecol Scand 1996;75(9):816–819
   PubMed Web of Science ®Google Scholar
• Qureshi IA. Intraocular pressure: association with menstrual cycle, pregnancy and menopause in apparently healthy women. Chin J Physiol 1995;38(4):229–234. Erratum: Chin J Physiol 1996;39:1–63
   PubMedGoogle Scholar
• Green K, Phillips CI, Cheeks L, Slagle T. Aqueous humor flow rate and intraocular pressure during and after pregnancy. Ophthalmic Res 1988;20(6):353–357
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol 1988;105(3):258–260
   PubMed Web of Science ®Google Scholar
• Wilke K. Episcleral venous pressure and pregnancy. Acta Ophthalmol Suppl 1975;125:40–41
   PubMedGoogle Scholar
• Affinito P, Di Spiezio Sardo A, Di Carlo C, et al. Effects of hormone replacement therapy on ocular function in postmenopause. Menopause 2003;10:482–487
   PubMed Web of Science ®Google Scholar
• Altintaş O, Caglar Y, Yuksel N, et al. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004;218:120–129
   PubMed Web of Science ®Google Scholar
• Coksuer H, Ozcura F, Oghan F, et al. Effects of estradiol–drospirenone on ocular and nasal functions in postmenopausal women. Climacteric 2011;14:482–4487
   PubMed Web of Science ®Google Scholar
• Sator MO, Joura EA, Frigo P, et al. Hormone replacement therapy and intraocular pressure. Maturitas 1997;28:55–58
   PubMed Web of Science ®Google Scholar
• Tint NL, Alexander P, Tint KM, et al. Hormone therapy and intraocular pressure in nonglaucomatous eyes. Menopause 2010;17:157–160
   PubMed Web of Science ®Google Scholar
• Treister G, Mannor S. Intraocular pressure and outflow facility. Effect of estrogen and combined estrogen-progestin treatment in normal human eyes. Arch Ophthalmol 1970;83:311–318
   PubMedGoogle Scholar
• Uncu G, Avci R, Uncu Y, et al. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol 2006;22:501–505
   PubMed Web of Science ®Google Scholar
• Abramov Y, Borik S, Yahalom C, et al. Does postmenopausal hormone replacement therapy affect intraocular pressure? J Glaucoma 2005;14(4):271–275
   PubMed Web of Science ®Google Scholar
• Guaschino S, Grimaldi E, Sartore A, et al. Visual function in menopause: the role of hormone replacement therapy. Menopause 2003;10(1):53–57
   PubMed Web of Science ®Google Scholar
• Toker E, Yenice O, Temel A. Influence of serum levels of sex hormones on intraocular pressure in menopausal women. J Glaucoma 2003;12(5):436–440
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Talwar N, Nan B, et al. The potential association between postmenopausal hormone use and primary open-angle glaucoma. JAMA Ophthalmol 2014;132(3):298–303
   PubMed Web of Science ®Google Scholar
• Pasquale LR, Loomis SJ, Weinreb RN, et al. Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States. Mol Vis 2013;19:1471–1481
   PubMed Web of Science ®Google Scholar
• Ball P, Knuppen R. Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol Suppl (Copenh) 1980;232:1–127
   PubMedGoogle Scholar
• Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373–376
   PubMed Web of Science ®Google Scholar
• Fuchsjager-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 2004;45:834–839
   PubMed Web of Science ®Google Scholar
• Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology 2008; 115: 246–252
   PubMed Web of Science ®Google Scholar
• Tunny TJ, Richardson KA, Clark CV. Association study of the 5′ flanking regions of endothelial-nitric oxide synthase and endothelin-1 genes in familial primary open-angle glaucoma. Clin Exp Pharmacol Physiol 1998;25:26–29
   PubMed Web of Science ®Google Scholar
• da Silva TM, Rocha AV, Lacchini R, et al. Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population. Gene 2012;502(2):142–146
   PubMed Web of Science ®Google Scholar
• Liao QO, Wang DH, Sun HJ. Association of genetic polymorphisms of eNOS with glaucoma. Mol Vis 2011;17(17–20):153–158
   PubMed Web of Science ®Google Scholar
• Logan JF, Chakravarthy U, Hughes AE, et al. Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and a history of migraine. Invest Ophthalmol Vis Sci 2005;46:3221–6
   PubMed Web of Science ®Google Scholar
• Ayub H, Khan MI, Micheal S, et al. Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts. Mol Vis 2010;16(2–3):18–25
   PubMed Web of Science ®Google Scholar
• Kang JH, Wiggs JL, Rosner BA, et al. The relation between endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with gender and postmenopausal hormone use. Invest Ophthalmol Vis Sci 2010;51:971–979
   PubMed Web of Science ®Google Scholar
• Emam WA, Zidan HE, Abdulhalim BE, et al. Endothelial nitric oxide synthase polymorphisms and susceptibility to high-tension primary open-angle glaucoma in an Egyptian cohort. Mol Vis 2014;20:804–811
   PubMed Web of Science ®Google Scholar
• Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002;23:665–686
   PubMed Web of Science ®Google Scholar
• Buys ES, Ko YC, Alt C, et al. Soluble guanylate cyclase β1-deficient mice: a novel murine model for primary open angle glaucoma. PLoS One 2013;8(3):e60156
   PubMed Web of Science ®Google Scholar
• Kang JH1, Wiggs JL, Haines J, et al. Reproductive factors and NOS3 variant interactions in primary open-angle glaucoma. Mol Vis 2011;17:2544–2551
   PubMed Web of Science ®Google Scholar
• Russo R, Cavaliere F, Watanabe C, et al. 17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res 2008;173:583–590
   PubMed Web of Science ®Google Scholar
• Tatrai KP, Xin H, Nguyen V, et al. 17β-Estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma. Mol Pharm 2013;10(8):3253–3261
   PubMed Web of Science ®Google Scholar
• Bigsby RM, Cardenas H, Caperell–Grant C, Grubbs CJ. Protective effects of estrogen in a rat model of age-related cataracts. Proc Natl Acad Sci USA 1999;96:9328–9332
   PubMed Web of Science ®Google Scholar
• Yamashita H, Sugihara K, Yamada C, et al. Effect of estrogen on electroretinographic responses in streptozotocin-induced diabetic female rats. Exp Eye Res 2010;90:591–597
   PubMed Web of Science ®Google Scholar
• Kaarniranta K, Machalińska A, Veréb Z, et al. Estrogen signalling in the pathogenesis of age-related macular degeneration. Curr Eye Res 2015;40(2):226–233
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA 2001;286:2114–2119
   PubMed Web of Science ®Google Scholar
• Bourque M, Dluzen DE, Di Paolo T. Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol 2009;30:142–157
   PubMed Web of Science ®Google Scholar
• Pike CJ, Carroll JC, Rosario ER, Barron AM. Protective actions of sex steroid hormones in Alzheimer’s disease. Front Neuroendocrinol 2009;30(2):239–258
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011;1379:188–198
   PubMed Web of Science ®Google Scholar
• Scott E, Zhang QG, Wang R, et al. Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol 2012;33(1):85–104
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305:1305–1314
   PubMed Web of Science ®Google Scholar
• Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: a randomized trial. JAMA 2003;289:2673–2684
   PubMed Web of Science ®Google Scholar
• Harman SM, Brinton EA, Clarkson T, et al. Is the WHI relevant to HRT started in the perimenopause? Endocrine 2004;24:195–202
   PubMed Web of Science ®Google Scholar
• Gadducci A, Cosio S, Genazzani AR. Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body. Curr Opin Invest Drugs 2004;5(10):1031–1044
   PubMedGoogle Scholar
• Paganini-Hill A, Clark LJ. Eye problems in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 2000;60(2):167–172
   PubMed Web of Science ®Google Scholar
• Advani P, Moreno-Aspitia A. Current strategies for the prevention of breast cancer. Breast Cancer (Dove Med Press) 2014;6:59–71
   PubMedGoogle Scholar